ATE171873T1 - Antiglucocorticoidsteroide zur behandlung von angststörungen - Google Patents

Antiglucocorticoidsteroide zur behandlung von angststörungen

Info

Publication number
ATE171873T1
ATE171873T1 AT94924819T AT94924819T ATE171873T1 AT E171873 T1 ATE171873 T1 AT E171873T1 AT 94924819 T AT94924819 T AT 94924819T AT 94924819 T AT94924819 T AT 94924819T AT E171873 T1 ATE171873 T1 AT E171873T1
Authority
AT
Austria
Prior art keywords
treatment
pct
anxiety disorders
antiglucocorticoid steroids
antiglucocorticoid
Prior art date
Application number
AT94924819T
Other languages
English (en)
Inventor
Bernardus Wynand Machi Peeters
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE171873T1 publication Critical patent/ATE171873T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94924819T 1993-08-04 1994-07-28 Antiglucocorticoidsteroide zur behandlung von angststörungen ATE171873T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93202304 1993-08-04

Publications (1)

Publication Number Publication Date
ATE171873T1 true ATE171873T1 (de) 1998-10-15

Family

ID=8214027

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94924819T ATE171873T1 (de) 1993-08-04 1994-07-28 Antiglucocorticoidsteroide zur behandlung von angststörungen

Country Status (11)

Country Link
US (1) US5741787A (de)
EP (1) EP0712311B1 (de)
JP (1) JP3828926B2 (de)
AT (1) ATE171873T1 (de)
AU (1) AU687088B2 (de)
CA (1) CA2166332C (de)
DE (1) DE69413829T2 (de)
DK (1) DK0712311T3 (de)
ES (1) ES2124905T3 (de)
NZ (1) NZ271363A (de)
WO (1) WO1995004536A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69500542T2 (de) * 1994-05-19 1998-01-02 Akzo Nobel Nv 11,21-Bisphenyl-19-nor-pregnan Derivate
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
IL119649A (en) * 1995-11-30 2002-03-10 Akzo Nobel Nv Preparation of Cyclic Kills of History - 3 keto- (5) 10, (-9) 11 steroidadians
ATE167190T1 (de) * 1995-12-22 1998-06-15 Jenapharm Gmbh Neue 17alpha-cyanomethylestra-4,9-dien-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
AU710139B2 (en) * 1996-05-01 1999-09-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The 21-substituted progesterone derivatives as new antiprogestational agents
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
FR2757400B1 (fr) * 1996-12-19 1999-12-17 Hoechst Marion Roussel Inc Application des composes antiglucocorticoides dans le traitement des psychoses ou des comportements addictifs
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
ES2230880T3 (es) * 1998-07-30 2005-05-01 Abbott Laboratories Agentes selectivos anti-inflmatorios de glucocorticoides.
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7250408B2 (en) 2002-12-16 2007-07-31 Bayer Schering Pharma Ag Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility
AU2004217988C1 (en) * 2003-02-28 2010-06-03 Southwest Foundation For Biomedical Research Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
US8097606B2 (en) * 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP1945240B1 (de) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Zusammensetzungen mit rezeptor-assoziierten protein (rap) varianten, die für cr-haltige proteine spezifisch sind und ihre verwendungen
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
CN108699102A (zh) 2015-12-23 2018-10-23 欧瑞克制药公司 糖皮质激素受体抑制剂
US11208432B2 (en) 2015-12-23 2021-12-28 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
WO2017112904A1 (en) 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
MX385658B (es) 2016-10-07 2025-03-18 Oric Pharmaceuticals Inc Inhibidores del receptor de glucocorticoides.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series

Also Published As

Publication number Publication date
EP0712311A1 (de) 1996-05-22
EP0712311B1 (de) 1998-10-07
AU687088B2 (en) 1998-02-19
DE69413829T2 (de) 1999-04-15
DK0712311T3 (da) 1999-06-21
ES2124905T3 (es) 1999-02-16
JPH09501172A (ja) 1997-02-04
US5741787A (en) 1998-04-21
NZ271363A (en) 1999-06-29
CA2166332A1 (en) 1995-02-16
WO1995004536A1 (en) 1995-02-16
DE69413829D1 (de) 1998-11-12
AU7496894A (en) 1995-02-28
CA2166332C (en) 2005-05-10
JP3828926B2 (ja) 2006-10-04

Similar Documents

Publication Publication Date Title
ATE171873T1 (de) Antiglucocorticoidsteroide zur behandlung von angststörungen
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
ATE253892T1 (de) Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
ATE241362T1 (de) Zusammensetzung zur substitutionstherapie, die mindestens ein progestogen und mindestens ein oestrogen enthält
DE60122767D1 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
MY141384A (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
ATE172963T1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
ATE346867T1 (de) Rekombinante il-5 antagonisten für die behandlung von il-5 bedingten krankheiten
BR9913072A (pt) Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia
DK0989973T3 (da) Chalconer med antiproliferativ aktivitet
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
BG103060A (bg) 19- нор- холан стероиди като неврохимични инициатори на промяната в действието на хипоталамуса причовек
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
DE60122764D1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
BR0010338A (pt) Composto enanciomericamente enriquecido, composição farmacêutica, método para tratar uma doença ou condição mediada por cck-a, uso de um composto, e, processo para a preparação de um composto
ATE168697T1 (de) Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen
ES2123796T3 (es) Derivados de acidos fosfono-succinicos y su utilizacion como medicamentos.
DE59409813D1 (de) Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen
ATA57894A (de) Mittel zur behandlung von osteoporose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification